Citation Impact
Citing Papers
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
Intensive versus Conventional Glucose Control in Critically Ill Patients
2009 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial
2009 Standout
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
2016 Standout
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
2015
Trends in case-fatality in 117718 patients admitted with acute myocardial infarction in Scotland
2000
The prognosis of heart failure in the general population. The Rotterdam Study
2001
Severe Hypoglycemia and Risks of Vascular Events and Death
2010 Standout
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
2003
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control*
2003 Standout
Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome
2000
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Bivalirudin during Primary PCI in Acute Myocardial Infarction
2008 Standout
Acute hyperglycemia exacerbates myocardial ischemia/reperfusion injury and blunts cardioprotective effect of GIK
2007
The metabolic syndrome
2010 Standout
Relationship Between Spontaneous and Iatrogenic Hypoglycemia and Mortality in Patients Hospitalized With Acute Myocardial Infarction
2009
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes
2005
Insulin as an anti-inflammatory and antiatherosclerotic hormone
2003
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
2015 Standout
Management of Hyperglycemia in the Hospital Setting
2006
Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D)
2005
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 Standout
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin–Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study
2011
Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting
2003
Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
2006
Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
2013 Standout
A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Adenosine as an Adjunct to Reperfusion in the Treatment of Acute Myocardial Infarction (AMISTAD-II)
2005
Sepsis and septic shock
2018 Standout
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
2006 Standout
Type 2 diabetes
2017 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
2002 Standout
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
2015 Standout
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
2008 Standout
Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes
2004
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients
2003
Stress-Induced Hyperglycemia
2001
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
2007
Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice
2007
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
2007 Standout
Obesity and the Risk of Heart Failure
2002 Standout
Confidence Limits Made Easy: Interval Estimation Using a Substitution Method
1998
Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes
2014
Myocardial Reperfusion Injury
2007 Standout
The Pathophysiology and Treatment of Sepsis
2003 Standout
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Early versus Late Parenteral Nutrition in Critically Ill Adults
2011 Standout
Normalization of Glucose Concentrations and Deceleration of Gastric Emptying after Solid Meals during Intravenous Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes
2003
Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?
2012
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
2003
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction
2003 Standout
Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients
2009
Proinflammatory Effects of Glucose and Anti-Inflammatory Effect of Insulin: Relevance to Cardiovascular Disease
2006
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
2011
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Intensive Insulin Therapy in the Medical ICU
2006 Standout
The immunopathogenesis of sepsis
2002 StandoutNature
Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview
2000 Standout
Management of Diabetes and Hyperglycemia in Hospitals
2004
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
2007
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels
2003
Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events
2005
Type 2-diabetes og det metaboliske syndrom - diagnostik og behandling
2000
Calculating the number needed to treat for trials where the outcome is time to an event
1999
Glucometrics in Patients Hospitalized With Acute Myocardial Infarction
2008
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Nowy rok, stare problemy, ale i nowe możliwości
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Strict Glucose Control Does Not Affect Mortality after Aneurysmal Subarachnoid Hemorrhage
2009
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Effects of insulin resistance on endothelial progenitor cells and vascular repair
2009
3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes
2003
Sudden cardiac death: the lost fatty acid hypothesis
2006
New Drugs for the Treatment of Diabetes
2008
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial
2003 Standout
Serious Cardiovascular Outcomes in Diabetes
2011
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
2012 Standout
Insulin Resistance and Atherosclerosis
2006
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
[Management of hyperglycemia in the hospitalized patient].
2010
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Works of K. Malmberg being referenced
Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
1997
Mortality prediction in diabetic patients with myocardial infarction: experiences from the DIGAMI study
1997
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction
1996
Abnormal glucose tolerance – a common risk factor in patients with acute myocardial infarction in comparison with population‐based controls
2004
Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.
1999
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity
2005